Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiology | 8 | 2023 | 106 | 5.430 |
Why?
|
| Artificial Intelligence | 8 | 2023 | 241 | 4.160 |
Why?
|
| Intestinal Volvulus | 8 | 2025 | 37 | 2.530 |
Why?
|
| Digestive System Abnormalities | 8 | 2025 | 37 | 2.370 |
Why?
|
| Ultrasonography | 12 | 2025 | 940 | 2.230 |
Why?
|
| Tomography, X-Ray Computed | 11 | 2023 | 2100 | 1.730 |
Why?
|
| Intestinal Obstruction | 2 | 2024 | 93 | 1.630 |
Why?
|
| Radiology Information Systems | 3 | 2024 | 23 | 1.620 |
Why?
|
| Radiologists | 7 | 2022 | 45 | 1.590 |
Why?
|
| Foreign Bodies | 3 | 2021 | 103 | 1.370 |
Why?
|
| Child | 37 | 2025 | 24384 | 1.150 |
Why?
|
| Pediatrics | 4 | 2024 | 1149 | 0.940 |
Why?
|
| Diagnostic Imaging | 4 | 2024 | 277 | 0.900 |
Why?
|
| Appendicitis | 2 | 2024 | 128 | 0.880 |
Why?
|
| Pandemics | 5 | 2022 | 1105 | 0.870 |
Why?
|
| Intussusception | 2 | 2022 | 48 | 0.870 |
Why?
|
| Workflow | 2 | 2021 | 118 | 0.860 |
Why?
|
| Device Approval | 1 | 2023 | 12 | 0.850 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2023 | 19 | 0.850 |
Why?
|
| Lung Neoplasms | 2 | 2023 | 1662 | 0.830 |
Why?
|
| Radiation Protection | 1 | 2023 | 54 | 0.830 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2023 | 24 | 0.830 |
Why?
|
| Clinical Decision-Making | 1 | 2024 | 264 | 0.790 |
Why?
|
| Radiography | 7 | 2023 | 821 | 0.780 |
Why?
|
| Thyroid Nodule | 1 | 2021 | 19 | 0.720 |
Why?
|
| Outpatients | 1 | 2023 | 253 | 0.720 |
Why?
|
| Radiology Department, Hospital | 2 | 2020 | 24 | 0.710 |
Why?
|
| Duodenum | 1 | 2021 | 99 | 0.710 |
Why?
|
| Burnout, Professional | 1 | 2023 | 117 | 0.710 |
Why?
|
| Humans | 48 | 2025 | 125086 | 0.700 |
Why?
|
| Teleradiology | 1 | 2020 | 5 | 0.700 |
Why?
|
| Fractures, Bone | 1 | 2022 | 187 | 0.690 |
Why?
|
| Multi-Institutional Systems | 1 | 2020 | 12 | 0.680 |
Why?
|
| Nuclear Medicine | 1 | 2020 | 8 | 0.680 |
Why?
|
| Hospitals, Community | 1 | 2020 | 55 | 0.660 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2021 | 222 | 0.660 |
Why?
|
| Child Health Services | 1 | 2020 | 87 | 0.630 |
Why?
|
| Shift Work Schedule | 1 | 2019 | 19 | 0.630 |
Why?
|
| Hospitals, Pediatric | 2 | 2022 | 760 | 0.620 |
Why?
|
| Thyroid Neoplasms | 1 | 2021 | 190 | 0.610 |
Why?
|
| Play and Playthings | 1 | 2018 | 17 | 0.600 |
Why?
|
| Digestive System | 1 | 2018 | 62 | 0.590 |
Why?
|
| Quality Assurance, Health Care | 1 | 2019 | 208 | 0.560 |
Why?
|
| Referral and Consultation | 1 | 2021 | 542 | 0.550 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2020 | 731 | 0.500 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2018 | 224 | 0.490 |
Why?
|
| Societies, Medical | 3 | 2024 | 696 | 0.460 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2023 | 3570 | 0.450 |
Why?
|
| Retrospective Studies | 14 | 2025 | 16326 | 0.430 |
Why?
|
| Radiation Dosage | 4 | 2023 | 135 | 0.420 |
Why?
|
| Sensitivity and Specificity | 6 | 2023 | 2054 | 0.410 |
Why?
|
| Positron-Emission Tomography | 2 | 2011 | 305 | 0.400 |
Why?
|
| Clinical Competence | 1 | 2019 | 1002 | 0.390 |
Why?
|
| Whole Body Imaging | 1 | 2011 | 29 | 0.360 |
Why?
|
| Infant | 13 | 2025 | 12476 | 0.340 |
Why?
|
| Laryngitis | 1 | 2009 | 7 | 0.330 |
Why?
|
| Tracheitis | 1 | 2009 | 14 | 0.330 |
Why?
|
| Croup | 1 | 2009 | 12 | 0.330 |
Why?
|
| Bronchitis | 1 | 2009 | 34 | 0.330 |
Why?
|
| Hospitals | 2 | 2023 | 389 | 0.320 |
Why?
|
| Child, Preschool | 12 | 2025 | 14005 | 0.310 |
Why?
|
| Lymphoma | 1 | 2011 | 322 | 0.290 |
Why?
|
| Surveys and Questionnaires | 3 | 2023 | 3728 | 0.280 |
Why?
|
| Heart Injuries | 1 | 2007 | 46 | 0.280 |
Why?
|
| Thoracic Injuries | 1 | 2007 | 90 | 0.270 |
Why?
|
| Angiography | 1 | 2007 | 215 | 0.270 |
Why?
|
| Hematoma | 1 | 2007 | 93 | 0.270 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2007 | 214 | 0.240 |
Why?
|
| Adolescent | 11 | 2025 | 19351 | 0.240 |
Why?
|
| Infant, Newborn | 6 | 2025 | 8202 | 0.240 |
Why?
|
| Reproducibility of Results | 4 | 2021 | 2890 | 0.230 |
Why?
|
| Aorta | 1 | 2007 | 545 | 0.220 |
Why?
|
| Adult | 5 | 2023 | 29632 | 0.210 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2023 | 50 | 0.210 |
Why?
|
| Vascular Malformations | 1 | 2024 | 88 | 0.210 |
Why?
|
| Esophagus | 2 | 2021 | 221 | 0.200 |
Why?
|
| Urography | 2 | 2013 | 31 | 0.200 |
Why?
|
| Dissent and Disputes | 1 | 2022 | 32 | 0.200 |
Why?
|
| Ileal Diseases | 1 | 2022 | 21 | 0.190 |
Why?
|
| Tertiary Care Centers | 1 | 2021 | 235 | 0.170 |
Why?
|
| Quarantine | 1 | 2020 | 17 | 0.170 |
Why?
|
| Contrast Media | 2 | 2021 | 479 | 0.170 |
Why?
|
| Triage | 1 | 2021 | 137 | 0.170 |
Why?
|
| Cost-Benefit Analysis | 1 | 2023 | 509 | 0.170 |
Why?
|
| Efficiency, Organizational | 1 | 2020 | 53 | 0.170 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2011 | 147 | 0.170 |
Why?
|
| Observer Variation | 1 | 2021 | 299 | 0.170 |
Why?
|
| Intestines | 1 | 2024 | 577 | 0.170 |
Why?
|
| Workload | 1 | 2021 | 145 | 0.170 |
Why?
|
| Eye | 1 | 2021 | 227 | 0.160 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2021 | 171 | 0.160 |
Why?
|
| United States | 4 | 2024 | 10912 | 0.160 |
Why?
|
| Infection Control | 1 | 2020 | 155 | 0.160 |
Why?
|
| Diagnosis, Differential | 1 | 2024 | 1894 | 0.150 |
Why?
|
| Male | 14 | 2025 | 61463 | 0.140 |
Why?
|
| Patient Safety | 1 | 2022 | 400 | 0.140 |
Why?
|
| Female | 13 | 2025 | 66747 | 0.140 |
Why?
|
| Practice Guidelines as Topic | 2 | 2024 | 1267 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 287 | 0.130 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2018 | 242 | 0.130 |
Why?
|
| Algorithms | 1 | 2023 | 1629 | 0.130 |
Why?
|
| Software | 1 | 2021 | 683 | 0.130 |
Why?
|
| Young Adult | 4 | 2022 | 9052 | 0.130 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 357 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 372 | 0.120 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 606 | 0.120 |
Why?
|
| Urination | 1 | 2013 | 23 | 0.100 |
Why?
|
| Radiometry | 1 | 2013 | 38 | 0.100 |
Why?
|
| Urethra | 1 | 2013 | 84 | 0.100 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2013 | 81 | 0.100 |
Why?
|
| Texas | 1 | 2020 | 3587 | 0.090 |
Why?
|
| Case-Control Studies | 1 | 2018 | 3299 | 0.090 |
Why?
|
| Fluoroscopy | 1 | 2011 | 91 | 0.090 |
Why?
|
| Brain | 1 | 2023 | 2999 | 0.090 |
Why?
|
| Urologic Diseases | 1 | 2011 | 44 | 0.090 |
Why?
|
| Radiopharmaceuticals | 1 | 2011 | 167 | 0.090 |
Why?
|
| Documentation | 1 | 2011 | 113 | 0.080 |
Why?
|
| Neoplasm Staging | 1 | 2011 | 1275 | 0.070 |
Why?
|
| Aortography | 1 | 2007 | 202 | 0.070 |
Why?
|
| Craniotomy | 1 | 2006 | 109 | 0.060 |
Why?
|
| Intraoperative Complications | 1 | 2006 | 171 | 0.060 |
Why?
|
| Hypotension | 1 | 2006 | 187 | 0.060 |
Why?
|
| Vascular Neoplasms | 1 | 2024 | 32 | 0.060 |
Why?
|
| Necrosis | 1 | 2024 | 206 | 0.050 |
Why?
|
| Short Bowel Syndrome | 1 | 2024 | 65 | 0.050 |
Why?
|
| Hemangioma | 1 | 2024 | 93 | 0.050 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2024 | 121 | 0.050 |
Why?
|
| Enema | 1 | 2022 | 37 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 5175 | 0.050 |
Why?
|
| Bronchi | 1 | 2021 | 97 | 0.050 |
Why?
|
| Brain Injuries | 1 | 2006 | 769 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2024 | 634 | 0.040 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 54 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2020 | 163 | 0.040 |
Why?
|
| Body Composition | 1 | 2022 | 521 | 0.040 |
Why?
|
| Neuroimaging | 1 | 2021 | 339 | 0.040 |
Why?
|
| Length of Stay | 1 | 2024 | 1308 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2007 | 3456 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2024 | 12391 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2007 | 6597 | 0.030 |
Why?
|
| Risk Factors | 2 | 2007 | 10284 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2022 | 1563 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2022 | 946 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 1065 | 0.030 |
Why?
|
| Washington | 1 | 2013 | 32 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 3423 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 233 | 0.020 |
Why?
|
| Injections | 1 | 2011 | 155 | 0.020 |
Why?
|
| Time Factors | 2 | 2011 | 6327 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2021 | 6154 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 590 | 0.020 |
Why?
|
| Aged | 1 | 2007 | 19861 | 0.020 |
Why?
|
| Middle Aged | 1 | 2007 | 26926 | 0.020 |
Why?
|
| Body Weight | 1 | 2011 | 989 | 0.020 |
Why?
|
| Methyl Ethers | 1 | 2006 | 23 | 0.020 |
Why?
|
| Isoflurane | 1 | 2006 | 41 | 0.020 |
Why?
|
| Fentanyl | 1 | 2006 | 46 | 0.020 |
Why?
|
| Anesthesia, General | 1 | 2006 | 118 | 0.020 |
Why?
|
| Age Factors | 1 | 2006 | 2817 | 0.010 |
Why?
|
| Neoplasms | 1 | 2011 | 2792 | 0.010 |
Why?
|